arrow
R

Roopinder K. Sandhu

Cornell University
H指数:36
被引数:8,591

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LB-525394-01 CENTERS OF EXCELLENCE OPTIMAL MANAGEMENT PATHWAYS FOR ATRIAL FIBRILLATION SPECIALTY SERVICES EARLY RHYTHM CONTROL TREATMENT CARE PATHWAY: PRIMARY RESULTS OF THE COMPASS HEART RHYTHM SOCIETY QUALITY IMPROVEMENT INITIATIVE

卓越中心优化管理路径:心房颤动专科服务早期节律控制治疗护理路径:COMPASS心脏节律学会质量改进计划的主要结果

2026-04-150
PRE
Publisher Correction: Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial

出版商更正: 抗凝预防房颤缺血性卒中和神经认知功能障碍: BRAIN-AF随机临床试验

2026-02-040
OAAI
Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial

抗凝预防房颤患者缺血性卒中和神经认知功能障碍: BRAIN-AF随机临床试验

2026-01-070
OAAI
Current Challenges in Cardiac Device Management: Guidance for Practicing Clinicians: A Canadian Journal of Cardiology White Paper

心血管设备管理的当前挑战:临床实践指南——加拿大心脏病学杂志白皮书

2026-01-010
PRE
Rationale and Design of the Comparative Effectiveness of ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients at a Low Risk for Arrhythmic Death (CONTEMP-ICD) trial

RATIONALE AND DESIGN OF THE COMPARATIVE EFFECTIVENESS OF ICD VERSUS NON-ICD THERAPY IN CONTEMPORARY HEART FAILURE PATIENTS AT A LOW RISK FOR ARRHYTHMIC DEATH (CONTEMP-ICD)临床试验的原理与设计

2025-09-040
PRE
Cost-effectiveness of apixaban vs. aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial

阿哌沙班与阿司匹林在降低设备检测到心房颤动的高危患者血栓栓塞事件中的成本效益:ARTESiA试验的启示

2025-09-011
OAAI
Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: a subgroup analysis of ARTESiA

阿哌沙班用于由植入式心脏监护仪检测到的亚临床房颤患者的卒中预防:ARTESiA研究的亚组分析

2025-08-050
PRE
Recent-onset atrial fibrillation: challenges and opportunities

新发心房颤动:挑战与机遇

2025-08-0112
PRE
Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

设备检测到的亚临床心房颤动患者中心房颤动进展:ARTESiA试验的见解

2025-07-090
PRE
The hope and the hype of artificial intelligence for syncope management

人工智能在晕厥管理中的希望与炒作

2025-07-010
OA
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial

Asundexian或Apixaban在根据先前口服抗凝剂使用情况的心房颤动患者中的应用:OCEANIC-AF随机临床试验的亚组分析

2025-06-010
PRE
Criteria for the establishment of an atrial fibrillation center of excellence and key operational standards

卓越心房颤动中心建立的准则和关键运营标准

2025-04-230
OA
Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure

重新评估当代心力衰竭患者一级预防植入式心律转复除颤器的需求

2025-02-050
PRE